Stay updated on Nivolumab in IDH-Mutant Gliomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in IDH-Mutant Gliomas Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.6, replacing v3.6.5. This indicates a small version update in the site's backend or UI without changing the study content shown.
    Difference
    0.1%
    Check dated 2026-09-01T20:56:27.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5, signaling a minor maintenance/version update. No changes to study content or visible page functionality are indicated.
    Difference
    0.1%
    Check dated 2026-08-11T19:14:15.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page's revision version was updated to v3.6.4, indicating a small, behind-the-scenes update to the page template. It does not reflect substantive changes to the study details or eligibility.
    Difference
    0.0%
    Check dated 2026-07-28T15:10:46.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3. This indicates a minor platform update that does not alter the displayed study details.
    Difference
    0.1%
    Check dated 2026-07-07T01:01:42.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision updated to v3.6.2, indicating a minor template/renderer update applied to the study page. This change does not modify the study content or data fields.
    Difference
    0.1%
    Check dated 2026-06-29T18:55:54.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The page now shows 'No longer looking for participants,' signaling that enrollment is closed, and it also adds user guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study, along with a formatting tweak to the Intervention/Treatment header and a revision version update.
    Difference
    0.4%
    Check dated 2026-06-15T12:48:13.000Z thumbnail image

Stay in the know with updates to Nivolumab in IDH-Mutant Gliomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.